Publications
Detailed Information
OK-432 sclerotherapy in head and neck lymphangiomas: Long-term follow-up result
Cited 42 time in
Web of Science
Cited 47 time in Scopus
- Authors
- Issue Date
- 2009-01
- Publisher
- MOSBY-ELSEVIER
- Citation
- OTOLARYNGOLOGY-HEAD AND NECK SURGERY; Vol.140 1; 120-123
- Abstract
- INTRODUCTION: Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy. MATERIALS AND METHODS: Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected. RESULTS: Initial response rates were 83.5 percent and long-term response rates were 76.3 percent. CONCLUSION: initial and the long-term response rate were equally good for lymphangioma. (C) 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
- ISSN
- 0194-5998
- Language
- English
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.